Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD_RTAMB/P/CIR/2022/8 dated January 25, 2022, Aarti Drugs has informed that the Company has issued the Letter of Confirmation in lieu of Duplicate Share Certificate to the shareholder. Details enclosed.
The above information is a part of company’s filings submitted to BSE.